NeuCyte
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
319 Bernardo Ave, Mountain View, Califor...Phone Number
(650) 274-8199Website
www.neucyte.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NeuCyte
NeuCyte, Inc. is an early-stage biotechnology company dedicated to developing treatments for neurological diseases through its proprietary human iPSC-based technology platform. The company specializes in generating quality iPSC-derived neural cells for drug discovery, targeting conditions such as Alzheimer's, ALS, epilepsy, and autism. NeuCyte offers a range of services including custom cell production, assay development, and functional phenotypic assessment, aimed at optimizing CNS drug discovery. Their intended clients include biopharmaceutical companies and research institutions focused on advancing neurological treatments.Explore more
NeuCyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuCyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NeuCyte is spiking on competitors!
Click to see if NeuCyte had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at NeuCyte
Check if NeuCyte has recently received funding, and reach out quickly before it becomes old news!
NeuCyte, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on NeuCyte recently announced quarterly report
Funding: Get notified immidiatlly once NeuCyte has new funding data
Product Launch: Get notified when NeuCyte launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to NeuCyte
Compare insights from companies similar to NeuCyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NeuCyte is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NeuCyte is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeuCyte.
NeuCyte financials insights
Gather financial insights about NeuCyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$6.7M
2020
Debt
$350K
NeuCyte Tech Stack
A closer look at the technologies used by NeuCyte
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Award, Spending/Investment
Funding
NeuCyte has received an SBA PPP loan for $350,000-1 million from First Republic Bank, supporting the retention of 15 jobs.
Funding
NeuCyte News & Media
NeuCyte and REPROCELL enter distribution agreement in North America and Europe
SAN CARLOS, Calif. and YOKOHAMA, Japan, Sept. 25, 2019 /PRNewswire/ -- NeuCyte, Inc., and REPROCELL, Inc., today announced a new distributorship. Although NeuCyte has direct sales in North America, this new distributorship will grant REPROCELL customers access to NeuCyte's pure and...NeuCyte Licenses Promising Novel Compound for Treatment of Refractory Epilepsy and Related Neurological Disorders
SAN CARLOS, Calif., Sept. 24, 2019 /PRNewswire/ -- NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, today announced that it has entered into an exclusive license agreement with Trillium Therapeutics to advance an undisclosed...NeuCyte Licenses Its Novel Neuronal Programming Technology to Enable Academic Research
SUNNYVALE, Calif., Dec. 3, 2018 /PRNewswire/ -- NeuCyte, Inc., a leading neuroscience drug discovery company, announced that it has entered a license agreement with Boston Children's Hospital. As part of the agreement, Boston Children's has obtained a non-exclusive license from NeuCyte to ...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding NeuCyte
Sign Up For FreeTo access detailed company insights
NeuCyte, Inc. is an early-stage biotechnology company dedicated to developing treatments for neurological diseases through its proprietary human iPSC-based technology platform. The company specializes in generating quality iPSC-derived neural cells for drug discovery, targeting conditions such as Alzheimer's, ALS, epilepsy, and autism. NeuCyte offe... Read More
